176 related articles for article (PubMed ID: 9413088)
21. Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines.
Cibulski S; Rivera-Patron M; Suárez N; Pirez M; Rossi S; Yendo AC; de Costa F; Gosmann G; Fett-Neto A; Roehe PM; Silveira F
Vaccine; 2018 Jan; 36(1):55-65. PubMed ID: 29174676
[TBL] [Abstract][Full Text] [Related]
22. QS-21 Adjuvant: Laboratory-Scale Purification Method and Formulation Into Liposomes.
Brunner L; Barnier-Quer C; Collin N
Methods Mol Biol; 2017; 1494():73-86. PubMed ID: 27718186
[TBL] [Abstract][Full Text] [Related]
23. Effect of iscoms and their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses: comparison of spleen cells from mice inoculated with iscoms and/or matrix.
Fossum C; Bergström M; Lövgren K; Watson DL; Morein B
Cell Immunol; 1990 Sep; 129(2):414-25. PubMed ID: 2383899
[TBL] [Abstract][Full Text] [Related]
24. Advances in saponin-based adjuvants.
Sun HX; Xie Y; Ye YP
Vaccine; 2009 Mar; 27(12):1787-96. PubMed ID: 19208455
[TBL] [Abstract][Full Text] [Related]
25. Glycosyl compositions and structural characteristics of the potential immuno-adjuvant active saponins in the Quillaja saponaria Molina extract quil A.
van Setten DC; van de Werken G; Zomer G; Kersten GF
Rapid Commun Mass Spectrom; 1995; 9(8):660-6. PubMed ID: 7647364
[TBL] [Abstract][Full Text] [Related]
26. On the structure of immune-stimulating saponin-lipid complexes (iscoms).
Kersten GF; Spiekstra A; Beuvery EC; Crommelin DJ
Biochim Biophys Acta; 1991 Feb; 1062(2):165-71. PubMed ID: 2004105
[TBL] [Abstract][Full Text] [Related]
27. ISCOMs and ISCOMATRIX.
Sun HX; Xie Y; Ye YP
Vaccine; 2009 Jul; 27(33):4388-401. PubMed ID: 19450632
[TBL] [Abstract][Full Text] [Related]
28. Iscom, a delivery system for parenteral and mucosal vaccination.
Morein B; Villacrés-Eriksson M; Lövgren-Bengtsson K
Dev Biol Stand; 1998; 92():33-9. PubMed ID: 9554257
[TBL] [Abstract][Full Text] [Related]
29. Application of Quillaja saponaria extracts as oral adjuvants for plant-made vaccines.
Kirk DD; Rempel R; Pinkhasov J; Walmsley AM
Expert Opin Biol Ther; 2004 Jun; 4(6):947-58. PubMed ID: 15174976
[TBL] [Abstract][Full Text] [Related]
30. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses.
Schiött A; Larsson K; Manniche S; Kalliomäki S; Heydenreich AV; Dalsgaard K; Kirkby N
Int J Pharm; 2011 Jul; 414(1-2):312-20. PubMed ID: 21601626
[TBL] [Abstract][Full Text] [Related]
31. A rabies vaccine adjuvanted with saponins from leaves of the soap tree (Quillaja brasiliensis) induces specific immune responses and protects against lethal challenge.
Yendo AC; de Costa F; Cibulski SP; Teixeira TF; Colling LC; Mastrogiovanni M; Soulé S; Roehe PM; Gosmann G; Ferreira FA; Fett-Neto AG
Vaccine; 2016 Apr; 34(20):2305-11. PubMed ID: 27032516
[TBL] [Abstract][Full Text] [Related]
32. Hydration of lipid films with an aqueous solution of Quil A: a simple method for the preparation of immune-stimulating complexes.
Copland MJ; Rades T; Davies NM
Int J Pharm; 2000 Mar; 196(2):135-9. PubMed ID: 10699704
[TBL] [Abstract][Full Text] [Related]
33. Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function.
Soltysik S; Wu JY; Recchia J; Wheeler DA; Newman MJ; Coughlin RT; Kensil CR
Vaccine; 1995; 13(15):1403-10. PubMed ID: 8578817
[TBL] [Abstract][Full Text] [Related]
34. Foamy matters: an update on
Magedans YV; Yendo AC; Costa F; Gosmann G; Fett-Neto AG
Future Med Chem; 2019 Jun; 11(12):1485-1499. PubMed ID: 31304830
[TBL] [Abstract][Full Text] [Related]
35. Saponins from
Fleck JD; Betti AH; da Silva FP; Troian EA; Olivaro C; Ferreira F; Verza SG
Molecules; 2019 Jan; 24(1):. PubMed ID: 30621160
[No Abstract] [Full Text] [Related]
36. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex.
Kensil CR; Patel U; Lennick M; Marciani D
J Immunol; 1991 Jan; 146(2):431-7. PubMed ID: 1987271
[TBL] [Abstract][Full Text] [Related]
37. On the preparation, microscopic investigation and application of ISCOMs.
Myschik J; Lendemans DG; McBurney WT; Demana PH; Hook S; Rades T
Micron; 2006; 37(8):724-34. PubMed ID: 16750912
[TBL] [Abstract][Full Text] [Related]
38. Quillaja brasiliensis saponin-based nanoparticulate adjuvants are capable of triggering early immune responses.
Cibulski SP; Rivera-Patron M; Mourglia-Ettlin G; Casaravilla C; Yendo ACA; Fett-Neto AG; Chabalgoity JA; Moreno M; Roehe PM; Silveira F
Sci Rep; 2018 Sep; 8(1):13582. PubMed ID: 30206376
[TBL] [Abstract][Full Text] [Related]
39. Uptake and adjuvant activity of orally delivered saponin and ISCOM vaccines.
Sjölander A; Cox JC
Adv Drug Deliv Rev; 1998 Dec; 34(2-3):321-338. PubMed ID: 10837684
[TBL] [Abstract][Full Text] [Related]
40. ISCOMs: an adjuvant with multiple functions.
Sjölander A; Cox JC; Barr IG
J Leukoc Biol; 1998 Dec; 64(6):713-23. PubMed ID: 9850152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]